What's New

NEWS FROM HEALTH ANALYTICS

Health Analytics is a growing presence in the rapidly-evolving health care universe.  Check back often for updates on our company and the research we are undertaking to make a difference for our clients.

 


Health Analytics Published in American Journal of Managed Care

Health Analytics' paper, Opioid Analgesic–Treated Chronic Pain Patients at Risk for Problematic Use, has been published in The American Journal of Managed Care. This study demonstrated that over one-third of a sample of chronic pain patients receiving opioid medication evidenced potentially problematic opioid use, defined as either doctor shopping or dose escalation. These potentially problematic patients were also shown to incur significantly greater healthcare costs compared to a non-problematic, chronic pain control group. Findings suggest a need for closer monitoring of potentially problematic use patients, even in the absence of an opioid abuse or dependence diagnosis, and that the employment of interventions tailored to mitigate the effect of problematic use may result in significant cost savings.

Health Analytics' work represented at Academy of Managed Care Pharmacy 2013 Educational Conference

Health Analytics' work was represented at Academy of Managed Care Pharmacy 2013 Educational Conference in San Antonio, Texas on October 16-18, 2013. Abstracts presented include:

Use of National Quality Forum Measures in Rheumatoid Arthritis Patients in a Large Managed Care Population,

Attainment of National Quality Forum (NQF) measures by Rheumatoid Arthritis Patients Treated with DMARDs during 2010 or 2011

Demographic and Clinical Characteristics of Patients Before Initiating Adalimumab, Etanercept or Golimumab, and

The Use of Quality Indicators in Rheumatoid Arthritis Patients receiving Methotrexate in a Large Managed Care Population

Health Analytics accepted for publication in American Journal of Managed Care

Health Analytics' most recent paper, Characterizing Opioid Analgesic-Treated Chronic Pain Patients at Risk for Potentially Problematic Opioid Use, has been accepted for publication in American Journal of Managed Care. This study demonstrated that over one-third of a sample of chronic pain patients receiving opioid medication evidenced potentially problematic opioid use, defined as either doctor shopping or dose escalation. These potentially problematic patients were also shown to incur significantly greater healthcare costs compared to a non-problematic, chronic pain control group. Findings suggest a need for closer monitoring of potentially problematic use patients, even in the absence of an opioid abuse or dependence diagnosis, and that the employment of interventions tailored to mitigate the effect of problematic use may result in significant cost savings.

Health Analytics presented at ISPOR's 18th International Meeting

Health Analytics presented two posters at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 18th International Meeting in New Orleans, LA on May 18-22nd. A list of posters presented can be found here: ISPOR

Health Analytics Recently Published in Journal of Pain Research

Health Analytics was recently published in the Journal of Pain Research for a paper titled “Trajectories of Healthcare Service Utilization and Differences in Patient Characteristics among Adults with Specific Chronic Pain: Analysis of Health Plan Member Claims”.  Using claims data, the purpose of this study identified distinct trajectories of health care service utilization of chronic pain patients, and described the characteristic differences between trajectory groups.  This study has implications for managed care program implementation and resource management, as the results form a developed algorithm that employed a variety of accessible data elements to effectively discriminate between patients based on their pattern of high cost venue service utilization over time. PMID

The Treatment Research Institute (TRI) posted on their website two research briefs of manuscripts authored by Health Analytics

The Treatment Research Institute (TRI), a non-profit research and development group dedicated to developing evidence-based solutions to the problems of substance use, posted on their website two research briefs of manuscripts authored by Health Analytics. The institute collects, develops, and disseminates research briefs to synthesize key findings from peer-reviewed scientific journals into practical terms. The first brief  was for the manuscript entitled “Compliance with Buprenorphine Medication-Assisted Treatment and Relapse to Opioid Use” which was published in 2012 in The American Journal on Addictions. The second brief was for the manuscript “The Effect of Telephonic Patient Support on Treatment for Opioid Dependence: Outcomes at One Year Follow-up” which was published in 2012 in Addictive Behaviors.

Manuscript under review for the American Journal of Managed Care

Health Analytics has submitted a manuscript that aides managed care in identifying potential problematic opioid users in chronic pain patients.  Attempts to examine their prevalence among patients with chronic, non-malignant pain have produced estimates of addiction ranging between 0% and 50%, depending on criteria used to define addiction.  This work, which was also shown at Pain Week, used chronic pain patients from a national health plan and examined presence of doctor shopping or rapid dose escalation.

Health Analytics investigates characteristics and health care utilization of subcutaneous biologics for rheumatic disorders

Health Analytics has began an investigation into patient characteristics, health care utilization, and patterns of medication use for subcutaneous biologic for rheumatic disorder (i.e. rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis).  Biologic medicine for this disease state is a rapidly changing field, and better understanding to patient characteristics has implications for providers and payers.

Health Analytics examines opioid dependence across a sample of European Patients and Users

Health Analytics continues to evaluate characteristics, outcomes, and behaviors of opioid users and in the European Union.  Health Analytics has been active in the examination of various opioid patient, user, and physician datasets that have been collected for the past several years.  This investigation aims to better understand characteristics of people who seek prescription opioid therapy and the outcomes.

Peter Kardel, the Research Director at Health Analytics, published in Developmental Medicine and Child Neurology.

The Research Director at Health Analytics, Peter Kardel, has recently been published in Developmental Medicine and Child Neurology.  Peter helped to design and aided with the analytics of this study which examined autism spectrum disorder symptomatology found in children with the genetic disorder of neurofibromatosis type 1 (NF1).